Position in GSK
as of Jun 30, 2026
· filed Jul 29, 2026
Position Value
$8,561,077
-$499,244 QoQ
Shares Held
163,317
-0.5% QoQ
Ownership
0.008%
of shares outstanding
% of Portfolio
0.70%
of 13F equity value
Holder Rank
#119
of 1,032 holders
Holding Since
Mar 2020
6 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in GSK Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Robertson Stephens Wealth Management, LLC holds $81,626,025 across 10 Drug Manufacturers - General names. GSK ranks #5 (10.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
14,384 | $17,252,602 | |
| 2 | ABBV |
AbbVie Inc.
|
63,757 | $16,043,811 | |
| 3 | MRK |
Merck & Co., Inc.
|
89,372 | $11,484,302 | |
| 4 | AMGN |
Amgen Inc
|
24,525 | $8,880,993 | |
| 5 | GSK |
GSK plc
This page
|
163,317 | $8,561,077 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
52,607 | $6,646,368 | |
| 7 | JNJ |
Johnson & Johnson
|
24,885 | $6,320,043 | |
| 8 | PFE |
Pfizer Inc
|
148,619 | $3,578,745 |
All Filings in GSK
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $8,561,077 | 163,317 | Shares | Sole | 2026-07-29 | |
| 2026-03-31 | $9,060,321 | 164,166 | Shares | Sole | 2026-04-28 | |
| 2025-12-31 | $7,927,904 | 161,662 | Shares | Sole | 2026-02-02 | |
| 2022-06-30 | $245,491 | 5,750 | Shares | Sole | 2022-08-12 | |
| 2020-06-30 | $431,513 | 10,786 | Shares | Sole | 2020-08-12 | |
| 2020-03-31 | $792,936 | 21,337 | Shares | Sole | 2020-05-01 | |
| No filing history on record for this holder in this stock. | ||||||